Get started
Author

Kirsi Launonen

Observed names: K Launonen, K. Launonen
OpenAlex ID: A5089148574
A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma
2015 · R Silvennoinen, P Anttila, et al. · Bone Marrow Transplantation · 52
PDF
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group
2019 · Sini Luoma, Pekka Anttila, et al. · Annals of Hematology · 16
PDF
RVD + ASCT + Lenalidomide Maintenance Benefits Patients without High-Risk Cytogenetics and Results in Recovery of the Normal Plasma Cell Composition in Bone Marrow
2016 · Raija Silvennoinen, Pekka Anttila, et al. · Blood · 4
First-Line Combination with Proteasome Inhibitor-Based Treatment and Zoledronic Acid Is Effective in Reducing Later Fractures in Multiple Myeloma Irrespective of Multiple Myeloma Bone Disease at Diagnosis
2024 · Veera Eskelinen, Elise Nivakoski, et al. · Hematology Reports · 3
A Prospective Phase 2 Study to Assess Immunophenotypic Remission after Lenalidomide-Based Induction Followed By ASCT and Lenalidomide Maintenance in Patients with Newly Diagnosed Multiple Myeloma
2015 · Raija Silvennoinen, Pekka Anttila, et al. · Blood · 1
A randomized phase II study of stem cell mobilization with cyclophosphamide + G-CSF versus G-CSF alone after lenalidomide-based induction in multiple myeloma
2015 · R. Silvennoinen, P. Anttila, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
P-029: 1st line combination treatment with proteasome-inhibitor and zoledronic acid is effective in reducing later fractures in multiple myeloma irrespective of MM bone disease
2021 · Elise Nivakoski, Veera Eskelinen, et al. · Clinical Lymphoma Myeloma & Leukemia
A Randomized Comparison of Low-Dose Cyclophosphamide + G-CSF Versus G-CSF Alone Mobilization after Lenalidomide-Bortezomib-Dexamethasone (RVD) Induction in Multiple Myeloma
2014 · Raija Silvennoinen, Tuija Lundan, et al. · Blood
Works count: 8
Citation count: 77
H-index: 3
I10-index: 2
Year
Topic
Type